Growth reconstruction in juvenile idiopathic arthritis treated with etanercept

Clinical and Experimental Rheumatology

Volumn 21, Issue 6, 2003, Pages 779-784

  Schmeling, Heinrike ^a   Seliger, E ^a   Horneff, G ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Etanercept; Growth hormone; Insulin like growth factor; Juvenile idiopathic arthritis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CHLORAMBUCIL; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; CYTOKINE; ETANERCEPT; GLUCOCORTICOID; GOLD SALT; IMMUNOGLOBULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TUMOR NECROSIS FACTOR; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ANTIINFLAMMATORY ACTIVITY; ARTHRALGIA; ARTICLE; CATCH UP GROWTH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GROWTH RATE; GROWTH RETARDATION; HUMAN; JOINT STIFFNESS; JUVENILE RHEUMATOID ARTHRITIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; ANTHROPOMETRY; BODY HEIGHT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; EPIDEMIOLOGY; FOLLOW UP; GROWTH DISORDER; HOSPITALIZATION; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PROBABILITY; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ANTHROPOMETRY; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BODY HEIGHT; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MALE; PROBABILITY; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0346258207     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ANDERSON GB: Juvenile arthritis - Who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol 1999; 17: 367-74.
2. PETTY RE, SOUTHWOOD TR, BAUM J et al.: Revision of the proposed criteria for juvenile idiopathic arthritis: Durban 1997. J Rheumatol 1998; 25: 1991-4.
3. ANSELL BM: Prognosis in juvenile arthritis. Adv Exp Med Biol 1999; 455: 27-33.
4. PRIEUR AM, CHEDEVILLE G: Prognostic factors in juvenile idiopathic arthritis. Curr Rheumatol Rep 2001; 3: 371-8.
5. ALLEN RC, JIMENEZ M, COWELL CT: Insulin-like growth factor and growth hormone secretion in juvenile chronic arthritis. Ann Rheum Dis 1991; 50: 602-6.
6. POLITO C, STRANO CG, OLIVIERI AN et al.: Growth retardation in non-steroid treated juvenile rheumatoid arthritis. Scand J Rheumatol 1997; 26: 99-103.
7. SÄNGER L: Klinische Verlaufsuntersuchung der Wachstumsretardierung von Kindern mit rheumatoider Arthritis und Still-Syndrom. Mschr Kinderheilk 1974; 122: 331-6.
8. CHIKANZA IC: Neuroendocrine immune features of pediatric inflammatory rheumatic diseases. Ann NY Acad Sci 1999; 22: 876: 71-82.
9. HOPP RJ, DEGAN J, CORLEY K, LINDSLEY CB, CASSIDY JT: Evaluation of growth hormone secretion in children with juvenile rheumatoid arthritis and short stature. Nebraska Med J 1995; 3: 52-7.
10. BUTENANDT O: Rheumatoid arthritis and growth retardation in children: treatment with human growth hormone. Eur J Pediatr 1979; 130: 15-28.
11. BECHTOLD S, RIPPERGER P, MÜHLBAYER D et al.: GH therapy in juvenile chronic arthritis: results of a two-year controlled study on growth and bone. J Clin Endocrinol Metab 2001; 86: 5737-44.
12. HESSE V, JAEGER U, VOGEL H et al.: Wachstumsdaten deutscher Kinder von Geburt bis zu 18 Jahren. Sozialpädiatrie 1997; 19: 20-2.
13. LOVELL DJ, GIANNINI EH, REIFF A et al.: Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000; 342: 763-9.
14. GIANNINI EH, RUPERTO N, RAVELLI A, LOVELL DJ, FELSON DT, MARTINI A: Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202-9.
15. FALCINI F, TACCETTI G, TRAPANI S, TAFI L, VOLPI M: Growth retardation in juvenile chronic arthritis patients treated with steroids. Clin Exp Rheumatol 1991; 9: 37-40.
16. BENNETT AE, SILVERMAN ED, MILLER JJ, HINTZ RL: Insulin-like growth factors I and II in children with systemic onset juvenile arthritis. J Rheumatol 1988; 15: 655-8.
17. AITMAN TJ, PALMER RG, LOFTUS J et al.: Serum IGF-I levels and growth failure in juvenile chronic arthritis. Clin Exp Rheumatol 1989; 7: 557-61.
18. DAVIES UM, JONES J, REEVE J et al.: Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin. Arthritis Rheum 1997; 40: 332-40.
19. TSATSOULIS A, SIAMOPOULOU A, PETSOUKIS C, CHALLA A, BAIRAKTARI E, SEFERIADIS K: Study of growth hormone secretion and action in growth-retarded children with juvenile chronic arthritis (JCA). Growth Horm IGF Res 1999; 9: 143-9.
20. ALLEN DB, JULIUS JR, BREEN TJ, ATTIE KM: Treatment of glucocorticoid induced growth suppression with growth hormone. J Clin Endocrinol Metab 1998; 83: 2824-9.
21. HUPPERTZ HI, TSCHAMMLER A, HORWITZ AE, SCHWAB KO: Intra-articular corticosteroids for chronic arthritis in children: Efficacy and effects on cartilage and growth. J Pediatr 1995; 127: 317-21.
22. SAHA MT, VERRONEN P, LAIPPALA P, LENKO HL: Growth of prepubertal children with juvenile chronic arthritis. Acta Paediatr 1999; 88: 724-8.
23. SVANTESSON H: Treatment of growth failure with human growth failure with human growth hormone in patients with juvenile chronic arthritis. A pilot study. Clin Exp Rheumatol 1991; 9 (Suppl. 6): 47-50.
24. DAVIES UM, ROONEY M, PREECE MA, ANSELL BM, WOO P: Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone. J Rheumatol 1994; 21: 153-8.
25. TOUATI G, PRIEUR AM, RUIZ JC, NOEL M, CZERNICHOW P: Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition. J Clin Endocrinol Metab 1998; 83: 403-9.
26. SIMON D, TOUATI G, PRIEUR AM, RUIZ JC, CZERNICHOW P: Growth hormone treatment of short stature and metabolic dysfunction in juvenile chronic arthritis. Acta Paediatr 1999; 428 (Suppl.): 100-5.
27. RIVKEES SA, DANON M, HERRIN J: Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure. J Pediatr 1994; 125: 322-5.
28. ROONEY M, DAVIES UM, REEVE J, PREECE M, ANSELL BM, WOO PMM: Bone mineral content and bone mineral metabolism: Changes after growth hormone treatment in juvenile chronic arthritis. J Rheumatol 2000; 27: 1073-81.
29. TOUATI G, RUIZ JC, PORQUET D, KINDERMANS C, PRIEUR AM, CZERNICHOW P: Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy. J Rheumatol 2000; 27: 1287-93.